Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

Modified-Release Drug Delivery Systems: Classification

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Modified-Release Drug Delivery Systems: Drug Release Characteristics

Modified-Release Drug Delivery Systems: Drug Release Characteristics

Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...

Modified-Release Drug Delivery Systems: Rate-Programmed I

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Porous organosilica nanoparticles enable UV blocking and two-photon fluorescence imaging.

Journal of materials chemistry. B·2026

Same author

Chlorotoxin-functionalized mesoporous silica nanoparticles for pH-responsive paclitaxel delivery to Glioblastoma multiforme.

Heliyon·2025

Same author

A versatile gold leaf immunosensor with a novel surface functionalization strategy based on protein L and trastuzumab for HER2 detection.

Scientific reports·2025

Same author

Biosensors for Cancer Biomarkers Based on Mesoporous Silica Nanoparticles.

Biosensors·2024

Same author

Assessing the Acidic and Alkaline Recalcitrance of Covalently Modified Surface Amines on Ordered Mesoporous Carbon.

Langmuir : the ACS journal of surfaces and colloids·2024

Same author

Direct electrochemical reduction of graphene oxide thin film for aptamer-based selective and highly sensitive detection of matrix metalloproteinase 2.

Talanta·2024

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation

Published on: February 24, 2016

Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system.

Nikola Ž Knežević¹, Brian G Trewyn, Victor S-Y Lin

¹Department of Chemistry, Iowa State University, Ames, Iowa 50011-3111, USA. nikola.z.knezevic@gmail.com

Chemical Communications (Cambridge, England)

|January 18, 2011

Summary

This summary is machine-generated.

This study introduces a novel supramolecular system for controlled cargo release using visible light. The system utilizes functionalized silica nanoparticles that release loaded molecules upon light irradiation.

More Related Videos

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Related Experiment Videos

Last Updated: Jun 5, 2026

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation

Synthesis of Gold Nanoparticle Integrated Photo-responsive Liposomes and Measurement of Their Microbubble Cavitation upon Pulse Laser Excitation

Published on: February 24, 2016

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

Area of Science:

Materials Science
Nanotechnology
Photochemistry

Background:

Mesoporous silica nanoparticles (MSN) offer high surface area and tunable pore sizes for drug delivery applications.
Controlled release mechanisms are crucial for enhancing therapeutic efficacy and minimizing side effects.
Photoreponsive materials enable spatiotemporal control over cargo release.

Purpose of the Study:

To develop a visible light-responsive supramolecular assembly for cargo molecule release.
To functionalize mesoporous silica nanoparticles (MP-MSN) for cargo encapsulation and light-triggered release.
To investigate the release mechanism of encapsulated cargo upon visible light irradiation.

Main Methods:

Synthesis of mercaptopropyl-functionalized mesoporous silica nanoparticles (MP-MSN).
Loading of cargo molecules (Sulforhodamine 101) into the mesopores of MP-MSN.
Entrapment of cargo using mercaptopropyl-coordinated Ruthenium(II) bipyridine complexes (Ru(bpy)(2)(PPh3)-moieties).
Irradiation with visible light to induce cargo release.

Main Results:

Successful encapsulation of Sulforhodamine 101 within MP-MSN.
Demonstration of visible light-induced release of capping ligands and cargo molecules.
Characterization of the supramolecular assembly and its photoresponsive behavior.

Conclusions:

The developed supramolecular assembly provides an effective platform for visible light-controlled cargo release.
MP-MSN functionalized with Ru(bpy)(2)(PPh3)-moieties show promise for targeted delivery and triggered release applications.
This approach offers a new strategy for developing smart drug delivery systems activated by visible light.